| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jan 31, 2024 | Option Exercise | $14.54 | 57,499 | 836,035 | 3,772,547 | Feb 02, 2024, 05:25 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jan 31, 2024 | Sale | $32.35 | 57,499 | 1,860,019 | 3,734,778 | Feb 02, 2024, 05:25 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jan 02, 2024 | Sale | $31.01 | 9,952 | 308,637 | 3,720,366 | Jan 04, 2024, 05:25 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 20, 2023 | Sale | $28.54 | 12,000 | 342,480 | 3,725,000 | Dec 22, 2023, 05:04 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 25, 2023 | Sale | $24.21 | 24,338 | 589,223 | 3,737,000 | Oct 27, 2023, 06:23 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 18, 2023 | Option Exercise | $4.75 | 57,755 | 274,336 | 3,819,093 | Sep 20, 2023, 06:10 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 18, 2023 | Sale | $28.12 | 57,755 | 1,624,223 | 3,787,570 | Sep 20, 2023, 06:10 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | May 03, 2023 | Option Exercise | $2.01 | 54,928 | 110,405 | 3,816,266 | May 05, 2023, 07:04 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | May 03, 2023 | Sale | $39.14 | 54,928 | 2,149,882 | 3,761,338 | May 05, 2023, 07:04 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | May 04, 2023 | Option Exercise | $2.01 | 50,000 | 100,500 | 3,811,338 | May 05, 2023, 07:04 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | May 04, 2023 | Sale | $39.52 | 50,000 | 1,975,792 | 3,787,330 | May 05, 2023, 07:04 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 27, 2022 | Option Exercise | $30.79 | 40,624 | 1,250,679 | 3,469,856 | Sep 29, 2022, 05:15 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jul 07, 2022 | Option Exercise | $14.54 | 2,501 | 36,365 | 4,060,135 | Jul 11, 2022, 08:08 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Feb 11, 2022 | Option Exercise | $5.19 | 146,388 | 759,754 | 4,204,022 | Feb 14, 2022, 08:54 AM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Feb 11, 2022 | Sale | $51.91 | 146,388 | 7,598,865 | 4,163,169 | Feb 14, 2022, 08:54 AM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jan 07, 2022 | Option Exercise | $5.19 | 11,806 | 61,273 | 4,057,634 | Jan 07, 2022, 09:39 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 23, 2021 | Option Exercise | $5.19 | 11,806 | 61,273 | 3,245,828 | Dec 23, 2021, 09:52 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 15, 2021 | Sale | $67.56 | 60,000 | 4,053,431 | 3,253,165 | Dec 17, 2021, 08:14 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 20, 2021 | Sale | $66.23 | 15,000 | 993,450 | 3,329,022 | Oct 22, 2021, 05:58 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 22, 2021 | Sale | $65.63 | 50,000 | 3,281,532 | 3,284,852 | Oct 22, 2021, 05:58 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 18, 2020 | Option Exercise | $5.73 | 40,510 | 232,006 | 2,545,747 | Dec 22, 2020, 05:55 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 09, 2020 | Option Exercise | $2.01 | 38,676 | 77,739 | 2,543,913 | Dec 10, 2020, 07:07 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 09, 2020 | Sale | $69.06 | 38,676 | 2,670,805 | 2,527,187 | Dec 10, 2020, 07:07 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 08, 2020 | Option Exercise | $2.01 | 16,324 | 32,811 | 2,521,561 | Dec 10, 2020, 07:07 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 08, 2020 | Sale | $67.97 | 16,324 | 1,109,542 | 2,505,237 | Dec 10, 2020, 07:07 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 23, 2020 | Sale | $58.21 | 100,000 | 5,821,032 | 2,517,509 | Oct 23, 2020, 07:35 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Aug 13, 2020 | Option Exercise | $9.90 | 50,000 | 495,000 | 2,655,237 | Aug 14, 2020, 06:08 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Aug 13, 2020 | Sale | $41.35 | 50,000 | 2,067,500 | 2,605,237 | Aug 14, 2020, 06:08 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jun 25, 2020 | Sale | $38.81 | 100,000 | 3,881,017 | 2,605,260 | Jun 26, 2020, 06:02 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 24, 2019 | Sale | $63.50 | 83,333 | 5,291,646 | 1,805,237 | Dec 27, 2019, 04:54 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 12, 2019 | Sale | $67.50 | 100,000 | 6,749,630 | 2,048,684 | Dec 13, 2019, 06:35 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 13, 2019 | Sale | $66.73 | 83,333 | 5,560,489 | 1,962,952 | Dec 13, 2019, 06:35 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 03, 2019 | Sale | $61.58 | 12,033 | 740,952 | 2,079,925 | Dec 04, 2019, 06:48 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 02, 2019 | Sale | $69.15 | 37,967 | 2,625,570 | 2,116,160 | Dec 04, 2019, 06:48 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 10, 2019 | Option Exercise | $5.20 | 56,325 | 292,890 | 2,178,228 | Oct 11, 2019, 07:31 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 10, 2019 | Sale | $31.83 | 56,325 | 1,792,825 | 2,121,903 | Oct 11, 2019, 07:31 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 25, 2019 | Sale | $28.25 | 20,000 | 565,000 | 2,121,903 | Sep 27, 2019, 09:16 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 24, 2019 | Option Exercise | $5.10 | 66,645 | 339,889 | 2,208,548 | Sep 24, 2019, 09:12 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 24, 2019 | Sale | $28.20 | 66,645 | 1,879,240 | 2,154,576 | Sep 24, 2019, 09:12 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 20, 2019 | Option Exercise | $5.10 | 4,250 | 21,675 | 2,146,153 | Sep 24, 2019, 09:12 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 20, 2019 | Sale | $29.00 | 4,250 | 123,250 | 2,141,903 | Sep 24, 2019, 09:12 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 23, 2019 | Option Exercise | $5.10 | 41,755 | 212,950 | 2,183,658 | Sep 24, 2019, 09:12 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 23, 2019 | Sale | $29.04 | 41,755 | 1,212,565 | 2,141,903 | Sep 24, 2019, 09:12 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | May 24, 2019 | Option Exercise | $2.13 | 49,448 | 105,110 | 2,141,903 | May 29, 2019, 06:57 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Apr 03, 2019 | Sale | $19.30 | 50,000 | 965,000 | 2,092,455 | Apr 05, 2019, 06:57 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 19, 2018 | Sale | $13.92 | 90,000 | 1,252,800 | 1,542,455 | Dec 21, 2018, 05:15 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 12, 2018 | Sale | $14.07 | 90,000 | 1,266,300 | 1,632,455 | Dec 14, 2018, 05:18 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Nov 09, 2018 | Sale | $14.39 | 81,500 | 1,172,705 | 1,727,755 | Nov 09, 2018, 07:01 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 04, 2018 | Sale | $14.45 | 64,834 | 936,851 | 1,803,955 | Sep 05, 2018, 04:23 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Aug 31, 2018 | Sale | $14.45 | 100,000 | 1,445,000 | 1,868,789 | Sep 05, 2018, 04:23 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Mar 16, 2018 | Sale | $7.40 | 26,000 | 192,400 | 1,968,789 | Mar 16, 2018, 06:09 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Mar 13, 2018 | Sale | $7.43 | 100,000 | 743,000 | 2,194,789 | Mar 15, 2018, 06:58 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Mar 14, 2018 | Sale | $7.44 | 100,000 | 744,000 | 2,094,789 | Mar 15, 2018, 06:58 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Mar 15, 2018 | Sale | $7.41 | 100,000 | 741,000 | 1,994,789 | Mar 15, 2018, 06:58 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 13, 2016 | Option Exercise | $1.27 | 300,444 | 381,564 | 816,789 | Dec 15, 2016, 09:46 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jun 30, 2016 | Option Exercise | $5.09 | 15,772 | 80,279 | 1,117,233 | Jul 05, 2016, 06:11 PM | |
| ARWR | ARROWHEAD RESEARCH CORP | Anzalone Christopher Richard | Chief Executive Officer | Dec 30, 2015 | Option Exercise | $6.13 | 58,712 | 359,905 | 561,461 | Jan 04, 2016, 07:15 PM | |
| ARWR | ARROWHEAD RESEARCH CORP | Anzalone Christopher Richard | President and CEO | Oct 15, 2014 | Buy | $6.32 | 16,000 | 101,120 | 260,173 | Oct 15, 2014, 06:33 PM | |
| ARWR | ARROWHEAD RESEARCH CORP | Anzalone Christopher Richard | President and CEO | Oct 15, 2014 | Buy | $6.32 | 16,000 | 101,120 | 260,173 | Oct 15, 2014, 05:31 PM | |
| ARWR | ARROWHEAD RESEARCH CORP | Anzalone Christopher Richard | President and CEO | Aug 31, 2010 | Buy | $0.89 | 10,000 | 8,900 | 341,729 | Aug 31, 2010, 05:58 PM | |
| ARWR | ARROWHEAD RESEARCH CORP | Anzalone Christopher Richard | President and CEO | Aug 27, 2010 | Buy | $0.89 | 10,000 | 8,900 | 331,729 | Aug 30, 2010, 04:19 PM |
Menu